These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11007861)

  • 21. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.
    Shiha G; Seif S; Eldesoky A; Elbasiony M; Soliman R; Metwally A; Zalata K; Mikhail N
    Hepatol Int; 2017 May; 11(3):286-291. PubMed ID: 28425016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Schiavon JL; Filho RJ; Sampaio JP; Lanzoni VP; Silva AE; Ferraz ML
    Hepatology; 2007 Aug; 46(2):307-14. PubMed ID: 17634962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis].
    Park SY; Kang KH; Park JH; Lee JH; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
    Korean J Gastroenterol; 2004 Apr; 43(4):246-51. PubMed ID: 15100488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C.
    Tamaki N; Kurosaki M; Tanaka K; Suzuki Y; Hoshioka Y; Kato T; Yasui Y; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Izumi N
    J Viral Hepat; 2013 Jan; 20(1):72-6. PubMed ID: 23231087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C.
    Colli A; Colucci A; Paggi S; Fraquelli M; Massironi S; Andreoletti M; Michela V; Conte D
    World J Gastroenterol; 2005 Dec; 11(46):7318-22. PubMed ID: 16437635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
    Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
    Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF; Said AT; Cummings OW; Born LJ
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia.
    Abdo AA; Al Swat K; Azzam N; Ahmed S; Al Faleh F
    Ann Saudi Med; 2007; 27(2):89-93. PubMed ID: 17356320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
    Diktas H; Karacaer Z; Özturk II; Cicek H
    Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.
    Lin MS; Lin HS; Chung CM; Lin YS; Chen MY; Chen PH; Hu JH; Chou WN; Huang JC; Huang TJ
    BMJ Open; 2015 Sep; 5(9):e008797. PubMed ID: 26369802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-histological assessment of liver fibrosis in HCV infection.
    Mangoud AM; Sanad SM; Hendawy A; el-Hady G; el-Sherbiny GT
    J Egypt Soc Parasitol; 2004 Aug; 34(2):383-95. PubMed ID: 15287165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
    Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
    Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.
    Kobeisy MA; Morsy KH; Galal M; Sayed SK; Ashmawy MM; Mohammad FM
    Arab J Gastroenterol; 2012 Jun; 13(2):49-53. PubMed ID: 22980591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.